|
Volumn 64, Issue 7, 2005, Pages 1099-1100
|
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CD20 ANTIBODY;
CYCLOPHOSPHAMIDE;
FLUORODEOXYGLUCOSE;
HLA DR4 ANTIGEN;
MESNA;
MONOCLONAL ANTIBODY;
PREDNISOLONE;
RITUXIMAB;
STEROID;
ABDOMINAL AORTA;
ADJUVANT THERAPY;
AGED;
ARTICLE;
ASCENDING AORTA;
B LYMPHOCYTE;
BODY WEIGHT;
CASE REPORT;
DRUG UPTAKE;
ERYTHROCYTE SEDIMENTATION RATE;
EXTERNAL CAROTID ARTERY;
FEMALE;
GERIATRIC PATIENT;
GIANT CELL ARTERITIS;
HUMAN;
ILIAC ARTERY;
LYMPHOCYTE DEPLETION;
MOON FACE;
MUSCLE BIOPSY;
MUSCLE WEAKNESS;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RHEUMATIC POLYMYALGIA;
SIDE EFFECT;
STEROID THERAPY;
SUBCLAVIAN ARTERY;
TREATMENT OUTCOME;
WEIGHT GAIN;
ADJUVANTS, IMMUNOLOGIC;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOCYTE DEPLETION;
POSITRON-EMISSION TOMOGRAPHY;
PREDNISOLONE;
RADIOPHARMACEUTICALS;
TEMPORAL ARTERITIS;
|
EID: 21344460261
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.2005.036533 Document Type: Article |
Times cited : (107)
|
References (5)
|